Replication Kinetics of a Candidate Live-Attenuated Vaccine for Cache Valley Virus in Aedes albopictus
Open Access
- 9 November 2022
- journal article
- research article
- Published by SAGE Publications in Vector-Borne and Zoonotic Diseases
- Vol. 22 (11) , 553-558
Abstract
Background: The emergence or re-emergence of several orthobunyaviruses (order: Bunyavirales ; family: Peribunyaviridae ), including Cache Valley virus (CVV) and Oropouche virus, warrants the development and evaluation of candidate live-attenuated vaccines (LAVs). Ideally, these vaccines would elicit long-lasting immunity with one single immunization. Materials and Methods: Since the deletion of two virulence factors, NSs and NSm, has been shown to attenuate the virulence phenotype of orthobunyaviruses, phleboviruses, and nairoviruses, genetic manipulation of the viral genome is considered an effective strategy for the rational design of candidate LAVs for bunyaviruses across multiple families. In addition, the deletion of Rift Valley fever virus NSs and NSm genes has been shown to reduce transmission by mosquitoes. Results: In this study, the ability of a CVV mutant lacking the NSs and NSm genes (2delCVV) to replicate in intrathoracically injected Aedes albopictus was compared with the parental wild-type CVV (wtCVV) 6V633 strain. In contrast to the robust replication of wtCVV in injected mosquitoes, the multiplication kinetics of the 2delCVV mutant was reduced by more than a 100-fold. Conclusion: These results suggest that the deletion of NSm and NSs genes is a feasible approach to rationally design candidate orthobunyavirus LAVs that are highly attenuated in mosquitoes and, therefore, pose little risk of reversion to virulence and transmission.Keywords
This publication has 46 references indexed in Scilit:
- Role of Bunyamwera Orthobunyavirus NSs Protein in Infection of Mosquito CellsPLOS Neglected Tropical Diseases, 2012
- Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope GlycoproteinJournal of Virology, 2012
- Observations on rift valley fever virus and vaccines in EgyptVirology Journal, 2011
- Characterization of the Antigen Distribution and Tissue Tropisms of Three Phenotypically Distinct Yellow Fever Virus Variants in Orally Infected Aedes aegypti MosquitoesVector-Borne and Zoonotic Diseases, 2008
- Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgutJournal of General Virology, 2006
- Second Human Case of Cache Valley Virus DiseaseEmerging Infectious Diseases, 2006
- Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoesJournal of General Virology, 2005
- Life-Threatening Cache Valley Virus InfectionNew England Journal of Medicine, 1997
- Synthesis of Bunyavirus-specific Proteins in a Continuous Cell Line (XTC-2) Derived from Xenopus laevisJournal of General Virology, 1985
- Cache Valley Virus, a Previously Undescribed Mosquito-Borne AgentScience, 1959